{"id":"https://openalex.org/W7224813174","doi":"https://doi.org/10.36469/jheor.2026.170641","title":"Real-World Early Prostate-Specific Antigen Response Comparison Among Patients with Metastatic Castration Sensitive Prostate Cancer Treated with Apalutamide or Abiraterone Acetate in the United States","display_name":"Real-World Early Prostate-Specific Antigen Response Comparison Among Patients with Metastatic Castration Sensitive Prostate Cancer Treated with Apalutamide or Abiraterone Acetate in the United States","publication_year":2026,"publication_date":"2026-10-30","ids":{"openalex":"https://openalex.org/W7224813174","doi":"https://doi.org/10.36469/jheor.2026.170641"},"language":"en","primary_location":{"id":"doi:10.36469/jheor.2026.170641","doi":"https://doi.org/10.36469/jheor.2026.170641","is_oa":true,"landing_page_url":"https://doi.org/10.36469/jheor.2026.170641","pdf_url":null,"source":{"id":"https://openalex.org/S4210194146","display_name":"Journal of health economics and outcomes research","issn_l":"2326-697X","issn":["2326-697X","2327-2236"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","poland-20","russia-white-list-3"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Health Economics and Outcomes Research","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.36469/jheor.2026.170641","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5027449699","display_name":"Benjamin H. Lowentritt","orcid":"https://orcid.org/0000-0001-9306-5345","observed_orcids":["https://orcid.org/0000-0001-9306-5345"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Benjamin Lowentritt","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5160197821","display_name":"Mehmet A. Bilen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mehmet Bilen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002998007","display_name":"Sabree C Burbage","orcid":"https://orcid.org/0000-0002-5993-3679","observed_orcids":["https://orcid.org/0000-0002-5993-3679"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sabree Burbage","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070312141","display_name":"Charmi Patel","orcid":"https://orcid.org/0000-0003-3053-3193","observed_orcids":["https://orcid.org/0000-0003-3053-3193","https://orcid.org/0000-0002-4165-8576"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Charmi Patel","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004841700","display_name":"Fr\u00e9d\u00e9ric Kinkead","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Frederic Kinkead","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013545031","display_name":"Carmine Rossi","orcid":"https://orcid.org/0000-0001-5801-6927","observed_orcids":["https://orcid.org/0000-0001-5801-6927"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Carmine Rossi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003767401","display_name":"Gordon W. Wong","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gordon Wong","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111170813","display_name":"Dominic Pilon","orcid":"https://orcid.org/0000-0003-2380-1495","observed_orcids":["https://orcid.org/0000-0003-2380-1495"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Dominic Pilon","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5134701636","display_name":"Neal D. Shore","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Neal Shore","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":1500,"currency":"USD","value_usd":1500},"apc_paid":{"value":1500,"currency":"USD","value_usd":1500},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.87404668,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"213","last_page":"221"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10124","display_name":"Prostate Cancer Diagnosis and Treatment","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11221","display_name":"Bone health and treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/metastatic-hormone-sensitive-prostate-cancer","display_name":"metastatic hormone-sensitive prostate cancer","score":0.9559999704360962},{"id":"https://openalex.org/keywords/apalutamide","display_name":"apalutamide","score":0.9819999933242798},{"id":"https://openalex.org/keywords/abiraterone-acetate","display_name":"abiraterone","score":1.0},{"id":"https://openalex.org/keywords/psa-response","display_name":"PSA response","score":0.796999990940094},{"id":"https://openalex.org/keywords/androgen-receptor-pathway-inhibitors","display_name":"androgen receptor pathway inhibitors","score":0.9359999895095825},{"id":"https://openalex.org/keywords/community-urology-practice","display_name":"community urology practice","score":0.7009999752044678},{"id":"https://openalex.org/keywords/administrative-claims-data","display_name":"administrative claims data","score":0.7200000286102295},{"id":"https://openalex.org/keywords/inverse-probability-of-treatment-weighting","display_name":"inverse probability of treatment weighting","score":0.8289999961853027},{"id":"https://openalex.org/keywords/time-varying-treatment-effects","display_name":"time-varying treatment effects","score":0.656000018119812}],"concepts":[{"id":"https://openalex.org/C2775832370","wikidata":"https://www.wikidata.org/wiki/Q27888393","display_name":"Abiraterone acetate","level":5,"score":0.9742000102996826},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7893999814987183},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.6083999872207642},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.5501000285148621},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5396999716758728},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5163000226020813},{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.5109000205993652},{"id":"https://openalex.org/C50382708","wikidata":"https://www.wikidata.org/wiki/Q223218","display_name":"Proportional hazards model","level":2,"score":0.4650000035762787},{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.4523000121116638},{"id":"https://openalex.org/C2776551883","wikidata":"https://www.wikidata.org/wiki/Q1996756","display_name":"Enzalutamide","level":5,"score":0.43220001459121704},{"id":"https://openalex.org/C201903717","wikidata":"https://www.wikidata.org/wiki/Q1778788","display_name":"Cohort study","level":2,"score":0.4138999879360199},{"id":"https://openalex.org/C2779322244","wikidata":"https://www.wikidata.org/wiki/Q574820","display_name":"Antiandrogen","level":4,"score":0.41359999775886536},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.4004000127315521},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.3937999904155731},{"id":"https://openalex.org/C77350462","wikidata":"https://www.wikidata.org/wiki/Q1125472","display_name":"Confounding","level":2,"score":0.39079999923706055},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.37950000166893005},{"id":"https://openalex.org/C2781406297","wikidata":"https://www.wikidata.org/wiki/Q409450","display_name":"Prostate-specific antigen","level":4,"score":0.35589998960494995},{"id":"https://openalex.org/C2779484032","wikidata":"https://www.wikidata.org/wiki/Q25098668","display_name":"Antigen retrieval","level":3,"score":0.3174000084400177},{"id":"https://openalex.org/C156957248","wikidata":"https://www.wikidata.org/wiki/Q1862216","display_name":"Odds ratio","level":2,"score":0.2930000126361847},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.2605000138282776},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.25429999828338623},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.25369998812675476},{"id":"https://openalex.org/C2779915747","wikidata":"https://www.wikidata.org/wiki/Q17058619","display_name":"Inverse probability weighting","level":3,"score":0.2533000111579895}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.36469/jheor.2026.170641","doi":"https://doi.org/10.36469/jheor.2026.170641","is_oa":true,"landing_page_url":"https://doi.org/10.36469/jheor.2026.170641","pdf_url":null,"source":{"id":"https://openalex.org/S4210194146","display_name":"Journal of health economics and outcomes research","issn_l":"2326-697X","issn":["2326-697X","2327-2236"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","poland-20","russia-white-list-3"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Health Economics and Outcomes Research","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.36469/jheor.2026.170641","doi":"https://doi.org/10.36469/jheor.2026.170641","is_oa":true,"landing_page_url":"https://doi.org/10.36469/jheor.2026.170641","pdf_url":null,"source":{"id":"https://openalex.org/S4210194146","display_name":"Journal of health economics and outcomes research","issn_l":"2326-697X","issn":["2326-697X","2327-2236"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","poland-20","russia-white-list-3"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Health Economics and Outcomes Research","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320333204","display_name":"Winship Cancer Institute","ror":"https://ror.org/02gars961"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":24,"referenced_works":["https://openalex.org/W2036193982","https://openalex.org/W2126049444","https://openalex.org/W2159810380","https://openalex.org/W2620798309","https://openalex.org/W2938589827","https://openalex.org/W2947014957","https://openalex.org/W2963794755","https://openalex.org/W2995928704","https://openalex.org/W3119125273","https://openalex.org/W3158318954","https://openalex.org/W3210347387","https://openalex.org/W4200236956","https://openalex.org/W4301595892","https://openalex.org/W4322505162","https://openalex.org/W4360607961","https://openalex.org/W4389506762","https://openalex.org/W4401698523","https://openalex.org/W4402597979","https://openalex.org/W4403480179","https://openalex.org/W4403517563","https://openalex.org/W4403525239","https://openalex.org/W4404800133","https://openalex.org/W4408537506","https://openalex.org/W4412722996"],"related_works":["https://openalex.org/W7224855363","https://openalex.org/W4366416287","https://openalex.org/W4391303739","https://openalex.org/W7117448944","https://openalex.org/W4399394794","https://openalex.org/W4414893544","https://openalex.org/W4410237684","https://openalex.org/W7130710904","https://openalex.org/W7161938829","https://openalex.org/W4212808842"],"abstract_inverted_index":{"Background:":[0],"Despite":[1],"the":[2,11,50,68,92,126,165,195,202,211,218,270,318],"availability":[3,141],"of":[4,13,26,49,128,134,139,147,210,217,280,295,305,320],"several":[5],"androgen":[6],"receptor":[7],"pathway":[8],"inhibitors":[9],"for":[10],"treatment":[12,129,148,186,314],"patients":[14,58,193,200,231,285,321],"with":[15,59,88,99,183,228,233,286,289,299,322],"metastatic":[16],"castration-sensitive":[17],"prostate":[18],"cancer":[19],"(mCSPC),":[20],"there":[21],"has":[22],"been":[23],"a":[24,44,179,184,224,241],"lack":[25],"head-to-head":[27],"randomized":[28],"clinical":[29],"trials":[30],"to":[31,125,173,239,261,316],"evaluate":[32],"their":[33,111],"comparative":[34],"efficacy":[35],"in":[36,52,67,103,194,201,269],"this":[37,281],"population.":[38],"Objective:":[39],"This":[40],"real-world":[41],"study":[42,190,282],"provides":[43],"comprehensive":[45],"and":[46,86,123,171,198,215,266,272],"robust":[47],"comparison":[48],"decline":[51],"prostate-specific":[53],"antigen":[54],"\u226590%":[55],"(PSA90)":[56],"among":[57],"mCSPC":[60,100,287],"who":[61],"initiated":[62],"apalutamide":[63,104,196,213,234,271,290,310],"or":[64,105,116,131,137],"abiraterone":[65,106,203,220,229,273,300],"acetate":[66,107,204,221,274,301],"United":[69],"States.":[70],"Methods:":[71],"Clinical":[72],"data":[73,140],"were":[74,101,235],"collected":[75],"from":[76,91],"US":[77],"community":[78],"urology":[79],"practices":[80],"by":[81,157],"Precision":[82],"Point":[83],"Specialty":[84],"Analytics":[85],"linked":[87],"administrative":[89],"claims":[90],"Komodo":[93],"Health":[94],"Solutions":[95],"Research":[96],"Database.":[97],"Patients":[98],"included":[102,191],"cohorts":[108,166],"based":[109],"on":[110,115],"first":[112],"dispensation/paid":[113],"claim":[114],"after":[117,302],"September":[118],"17,":[119],"2019":[120],"(index":[121],"date),":[122],"followed":[124],"earliest":[127],"discontinuation":[130],"switch,":[132],"end":[133,138],"insurance/clinical":[135],"activity,":[136],"(Dec.":[142],"31,":[143],"2023).":[144],"Inverse":[145],"probability":[146],"weighting":[149],"balanced":[150],"potentially":[151],"confounding":[152],"patient":[153],"characteristics.":[154],"PSA90":[155,174,225,242,262,296],"response":[156,175,243,263,297],"6":[158,207,245,303],"months":[159,246,268,304],"post":[160],"index":[161],"was":[162,176,264],"compared":[163,177,298],"between":[164],"using":[167,178],"weighted":[168,180,212,219],"Kaplan-Meier":[169],"analysis":[170],"time":[172,260],"Cox":[181],"model":[182],"time-varying":[185],"effect.":[187],"Results:":[188],"The":[189,258,278],"1351":[192],"cohort":[197,214,222],"1003":[199],"cohort.":[205],"By":[206],"months,":[208],"61.4%":[209],"45.9%":[216],"achieved":[223],"response.":[226],"Compared":[227],"acetate,":[230],"treated":[232,288],"73%":[236],"more":[237],"likely":[238],"achieve":[240],"at":[244],"(weighted":[247],"hazard":[248],"ratio,":[249],"1.73;":[250],"95%":[251],"confidence":[252],"interval,":[253],"1.44-2.08;":[254],"P":[255],"<":[256],".001).":[257],"median":[259],"3.8":[265],"8.7":[267],"cohorts,":[275],"respectively.":[276],"Conclusions:":[277],"results":[279],"confirm":[283],"that":[284],"have":[291],"significantly":[292],"higher":[293],"rates":[294],"treatment.":[306],"Real-world":[307],"evidence":[308],"highlights":[309],"as":[311],"an":[312],"important":[313],"option":[315],"improve":[317],"prognosis":[319],"mCSPC.":[323]},"counts_by_year":[],"updated_date":"2026-11-01T11:40:01.658920","created_date":"2026-10-31T00:00:00"}